Catastrophic antiphospholipid antibody syndrome following initiation of hemodialysis

被引：3
作者：
Yotsueda H. [1 ]
Tsuruya K. [1 ]
Tokumoto M. [1 ]
Hirakata H. [1 ]
Iida M. [1 ]
机构：
[1] Department of Medicine and Clinical Science, Graduate School of Medicine and Science, Kyushu University, Higashi-ku, Fukuoka 812-8582
来源：
Clinical and Experimental Nephrology | 2005年 / 9卷 / 4期
关键词：
Catastrophic antiphospholipid antibody syndrome; Hemodialysis;
D O I：
10.1007/s10157-005-0387-2
中图分类号：
学科分类号：
摘要：
Antiphospholipid syndrome (APS) is associated with arterial and venous thrombosis, pregnancy morbidity, and thrombocytopenia. Some APS patients develop rapid and disseminated microthrombosis and are known as having catastrophic APS or CAPS. We document here a case of CAPS in a patient who presented with various clinical symptoms and serious abnormalities of blood coagulation following initiation of hemodialysis after bilateral nephrectomy due to renal cancer. The patient developed multiple organ symptoms, including melena, visual disturbances, skin eruptions, lymph node swelling, urinary tract bleeding, backache, arteriovenous fistula occlusion, and chest pain. Based on the clinical course and serological and histological examinations, a diagnosis of CAPS was established. The patient recovered by following intensive anticoagulation and steroid therapy. Although CAPS is rare, once symptoms develop the condition deteriorates rapidly. Because of the associated high mortality, early diagnosis and prompt treatment are necessary. © Japanese Society of Nephrology 2005.
引用
收藏
页码：335 / 339
页数：4
相关论文
共 10 条
  • [1] Kitchens C.S., Thrombotic storm: When thrombosis begets thrombosis, Am J Med, 104, pp. 381-5, (1998)
  • [2] Wilson W.A., Gharavi A.E., Koike T., Et al., International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop, Arthritis Rheum, 42, pp. 1309-11, (1999)
  • [3] Levine J.S., Branch D.W., Rauch J., The antiphospholipid syndrome, N Engl J Med, 346, pp. 752-63, (2002)
  • [4] Asherson R.A., The catastrophic antiphospholipid syndrome, J Rheumatol, 19, pp. 508-12, (1992)
  • [5] Asherson R.A., The catastrophic antiphospholipid syndrome, 1998. a review of the clinical features, possible pathogenesis and treatment, Lupus, 7, pp. 55-62, (1998)
  • [6] Erkan D., Cervera R., Asherson R.A., Catastrophic antiphospholipid syndrome: Where do we stand?, Arthritis Rheum, 48, pp. 3320-7, (2003)
  • [7] Jurgensen J.S., Kettritz R., Schneider W., Et al., Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis, Rheumatol Int, 23, pp. 204-6, (2003)
  • [8] Kaushik S., Federle M.P., Schur P.H., Krishnan M., Silverman S.G., Ros P.R., Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients, Radiology, 218, pp. 768-71, (2001)
  • [9] Asherson R.A., Cervera R., Piette J.C., Et al., Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients, Medicine (Baltimore), 77, pp. 195-207, (1998)
  • [10] Golden B.D., Belmont H.M., The role of microvasculopathy in catastrophic antiphospholipid syndrome: Comment on the article by Neuwelt et al, Arthritis Rheum, 41, pp. 751-3, (1998)
1